Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
about
Lipoxygenase products in inflammatory synovial fluids and other exudatesEnhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis.Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis.Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis.Expression of leukotriene receptors in the rat dorsal root ganglion and the effects on pain behaviors.5-Lipoxygenase inhibitors attenuate TNF-α-induced inflammation in human synovial fibroblastsOverview of recent drug discovery approaches for new generation leukotriene A4 hydrolase inhibitors.The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.Role of invading leukocytes in enhanced atrial eicosanoid production following rabbit left ventricular myocardial infarction.RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay.Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation.The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats.Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway.Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritisDietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis modelComplement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.Structure and ligand based drug design strategies in the development of novel 5- LOX inhibitors.Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling.Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids.A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss.Persisting eicosanoid pathways in rheumatic diseases.Critical Role of LTB4/BLT1 in IL-23-Induced Synovial Inflammation and Osteoclastogenesis via NF-κB.Eicosanoids in health and in disease: an appraisal.Arachidonic acid metabolism in neutrophil granulocytes obtained from synovial fluid in rheumatoid arthritis.Characterisation of soluble and cell associated phospholipase A2 from rheumatoid synovial fluid.NSAIDs revisited: selection, monitoring, and safe use.Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts.Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.Leukotriene enhances NMDA-induced inward currents in dorsal horn neurons of the rat spinal cord after peripheral nerve injury.Enhanced levels of leukotriene B(4) in synovial fluid in Lyme disease.Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis.Leukotriene b4 production by peripheral blood neutrophils in rheumatoid arthritis.IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.Effect of gedunin on acute articular inflammation and hypernociception in mice.LOX inhibitor HOEC interfered arachidonic acid metabolic flux in collagen-induced arthritis rats
P2860
Q28327097-F23DFEE6-03D6-487D-8B47-B9EBF1D9E77CQ33557557-C5AABDA3-686B-4233-B06D-4F9D4A0DD7D1Q33561121-8BA76407-2D75-4D0D-A36B-8F79C31F85A0Q34015417-A885BA61-D1BB-48B2-B203-A3A62667E812Q34173916-EC544AFD-C2AB-4FC2-8AE5-CA8138D96CDCQ34208803-14672BCA-9E19-49D5-BEDF-8A9B89FED34BQ34308008-ABA8F7C2-4C80-4C91-83AA-0CA28E4D7362Q34499286-D68AD041-4002-4693-AEED-79F61EFA1E57Q34564409-5B5B1EC9-5F32-4F33-84AA-5AB66C406CB6Q34945471-0C5E0E87-3DC3-4F10-B433-79887A4FECF4Q35041052-8BFB1466-5F08-4A4E-A210-9822CAEE5331Q35043650-A09600C3-8696-4BFF-9FD6-631780689266Q35045518-FD1E6BF4-2076-4A7D-BF45-B683DB3047A5Q35413883-5D2A2EF9-3F6A-4859-8420-FB6F4A7CBFCBQ35553767-14121CA7-241B-4738-A92B-CD1F851AD8A7Q35562274-09FA672E-FFB8-46CC-8C73-41F65BEE07F3Q35830260-1576D7D6-D717-4D90-B3A7-12578A16E132Q35874522-2F0E47C8-45B9-491C-889A-8F35D9A2E417Q35953220-BE2C16C2-9D33-44C1-B86E-91F841138A42Q36345885-7B28E0FC-883F-4F37-8980-D1336D6E57C5Q36414844-A2A1BC99-5368-4D0C-97A8-787A5B2DDD6BQ37270823-EBB6D9BB-F616-4DB3-89E0-E058720D5F9AQ37482102-7A11236C-BB0A-4355-A63C-BD1D305ACA45Q38186997-B6422E9D-0974-4FBC-B4F4-60DDD075FFE0Q39147426-7E5769E3-C55A-457F-8B77-F75C38A4A36CQ39493108-28AA6120-1ED1-414E-91D6-26CB47DFF76CQ41206361-B5674AAB-5F04-450F-BFAE-AD531D311C37Q41209285-98E73D21-9A06-497A-8086-C75B9D278BC8Q41360392-E675FD34-4BD0-4DB8-8021-9B150E37C85CQ42734942-FF75F997-2F01-4A55-A375-0F840B3A0E15Q42920908-CC866997-ECBE-436F-B126-EAB0C317F2C8Q43157098-07EA9C73-37A4-483C-868D-ED8CE763B6EFQ43203915-B222F691-F986-419A-8BD6-170FFA13C9C5Q43709166-FE24E779-8B03-4D5B-9793-0724C7E81ECBQ44636704-A8315474-E44B-4587-A3BC-68E4C829C908Q46450957-8FA908B8-C761-411C-A345-1CB3FD105A38Q46777140-422ADCF9-B39D-4C25-BB05-C770D83BB868Q58776025-B5744D94-1F36-49CF-8263-DE0BAAC2AA6F
P2860
Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
description
1983 nî lūn-bûn
@nan
1983 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@ast
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@en
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@nl
type
label
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@ast
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@en
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@nl
prefLabel
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@ast
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@en
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Leukotriene B4, a mediator of ...... fluid in rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1136/ARD.42.6.677
P407
P577
1983-12-01T00:00:00Z